Medical Cannabis

The bill clarifies that if marijuana is changed or removed from the list of controlled substances at the federal level, Tennessee's commissioner cannot make similar changes at the state level unless the state legislature has created a specific regulatory framework for marijuana. This means that any changes to marijuana's legal status must go through the General Assembly first.

TN SB1603 is a senate bill in the Tennessee 114th General Assembly, sponsored by Ferrell Haile (R), currently “Passed” since April 27, 2026.

We track 9,160 Tennessee bills this session, 129 of them sponsored by Ferrell Haile.

Supporters of the bill argue that it ensures state control over marijuana regulation, allowing the legislature to carefully consider how any changes to federal law should be implemented in Tennessee. This approach is seen as a way to maintain public safety and ensure that any marijuana-related policies are thoughtfully developed.

Critics of the bill contend that it unnecessarily limits the state's ability to adapt to changes in federal law regarding marijuana. They argue that this could hinder progress in medical cannabis access and create inconsistencies between state and federal regulations, potentially leaving patients without needed treatments.

Senator Ferrell Haile, as a pharmacist and owner of Perkins Drugs & Gift Shoppe, has direct involvement in the pharmaceuticals and health products industry, which aligns closely with the subject matter of SB1603 regarding medical cannabis. The bill aims to establish a regulatory framework for marijuana, which could potentially affect the pharmaceutical landscape, especially if cannabis is rescheduled or deleted as a controlled substance. Given Haile's professional background, there is a risk that his financial interests in the pharmaceutical sector could influence his legislative decisions regarding the regulation of medical cannabis.

Additionally, Haile's position as a board member of Sumner Regional Medical Center further intertwines his personal financial interests with the healthcare sector. If the bill leads to increased acceptance or regulation of medical cannabis, it could create new market opportunities within the healthcare industry, potentially benefiting his business interests. Thus, the alignment of his occupation and business ownership with the bill's impact raises significant concerns about potential conflicts of interest.

Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.

Items marked "AI-researched" are generated from public sources but have not been independently verified. Verified data is sourced from official legislature websites and disclosure filings.